Charlie Fazio, MD, senior vice president and medical director of HealthPartners discusses the uncertainty felt by practices as the industry moves from fee-for-service to value-based care.
Charlie Fazio, MD, senior vice president and medical director of HealthPartners discusses the uncertainty felt by practices as the industry moves from fee-for-service to value-based care
Transcript (slightly modified)
How do physicians balance the fact that the industry is moving toward value-based care, but they are mostly still practicing in a fee-for-service environment?
There’s a lot of uncertainty as people live in a fee-for-service world and we start to talk about a world where there might be more payments based on population. It’s tough for a practice to figure out "when do I go from A to B?" and so for a while they live with the ambiguity, they try to run both models even though at the same time, I want to treat everybody I see in the course of a day, the same way, according to the same model, without worrying about how I’m being paid for them. You can’t possibly keep track of all that.
So, in a lot of ways I think it’s important for a practice to think through: how do I coordinate the various contracts I have? How do I move more in the direction of population-based care? When will it be safe for me to think through: I want to run this as efficiently as I can, I want to run this based on cost rather than on revenue, and I want to go all-in on the team version.
That’s a tough decision and I think it’s incumbent on all of us. It’s important to all of us and we’ll all benefit from helping practices figure out how to go there.
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More